Proxy Votes Now

Home › Funds › Smead Value Fund

Smead Value Fund (SMVLX) proxy voting record 2025-2026

Fund family: Smead Funds Trust · Filed by Smead Funds Trust (CIK 1614370) · SEC series S000047006

Share classes and tickers: SMVLX (C000146928), SVFAX (C000146930), SVFCX (C000146929), SVFDX (C000146933), SVFFX (C000146931), SVFIX (C000146932), SVFKX (C000146934), SVFLX (C000146936), SVFMX (C000198929), SVFRX (C000146935), SVFSX (C000198930), SVFYX (C000146937)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 341 with, 31 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 31 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other Smead Funds Trust funds is possible: fewer than three other funds of the family voted in 2025-2026.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 372 such votes could be given a sector.

SectorVotesAgainst managementShare
Consumer Discretionary1241512.1%
Finance10887.4%
Energy5611.8%
Health Care45511.1%
Real Estate2300.0%
Technology16212.5%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2770
Say-on-Pay280
Audit-related260
Corporate Governance1611
Environment or Climate88
Compensation60
Human Rights or Human Capital/workforce66
Other Social Issues55
Extraordinary Transactions10
Shareholder Rights and Defenses11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
APA CORPORATIONMay 21, 2026$325M130
SIMON PROPERTY GROUP, INC.May 13, 2026$300M130
MERCK & CO., INC.May 26, 2026$295M183
AMGEN INC.May 19, 2026$267M151
THE MACERICH COMPANYJune 1, 2026$250M100
D.R. HORTON, INC.January 15, 2026$216M100
CONOCOPHILLIPSMay 12, 2026$194M161
TARGET CORPORATIONJune 10, 2026$192M183

Notable votes against management

MeetingCompanyProposalFundMgmt
May 26, 2026MERCK & CO., INC.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026MERCK & CO., INC.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 19, 2026AMGEN INC.Stockholder proposal to require an independent board chairman. Shareholder proposalAgainstFor
May 12, 2026CONOCOPHILLIPSStockholder Proposal - Independent Board Chairman. Shareholder proposalAgainstFor
June 10, 2026TARGET CORPORATIONShareholder proposal requesting policy requiring the Board Chair to be an independent director. Shareholder proposalAgainstFor
June 10, 2026TARGET CORPORATIONShareholder proposal requesting a report on presence of pesticides in Target's private label brands. Shareholder proposalAgainstFor
June 17, 2026EBAY INC.Special stockholder meeting threshold, if properly presented. Shareholder proposalAgainstFor
May 5, 2026AMERICAN EXPRESS COMPANYShareholder proposal requesting a report on coverage of transgender healthcare treatments for minors. Shareholder proposalAgainstFor
May 5, 2026AMERICAN EXPRESS COMPANYShareholder proposal regarding political bias risk oversight. Shareholder proposalAgainstFor
April 8, 2026LENNAR CORPORATIONVote on a stockholder proposal on Equal Voting Rights for Each Share. Shareholder proposalAgainstFor
April 8, 2026LENNAR CORPORATIONVote on a stockholder proposal on Disclosure of Voting Results by Share Class. Shareholder proposalAgainstFor
June 1, 2026UNITEDHEALTH GROUP INCORPORATEDIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor

Search this fund’s votes by company

374 ballot items at 27 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Smead Value Fund (SMVLX) voted at 27 shareholder meetings of 26 companies, on 374 ballot items in all. Where management made a recommendation, the fund followed it on 91.7% of the items and voted against it 31 times. Its most frequent area of disagreement was corporate governance (11 of its votes against management). It voted on 31 shareholder proposals.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.